EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

The Analgesic Efficacy and Safety of Intramuscular Hydromorphone Versus Butorphanol for Acute Pain in the Emergency Department: A Randomized Trial

Yongping Huang iD, Xiaojing Peng iD, Bihua Zhang iD, Li Luo iD, Yufang Sun iD, Hang Dai iD, Jimei Zhang iD, Jia Yin iD, Shiqiang Xiong iD, Tao Xiang iD

Pain Research and Management · 2026-01 · 2026 (1)

DOI: 10.1155/prm/4981039 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Research and Management, online erschienen am 16.06.2026. Verfasst von Yongping Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The Third People's Hospital of Chengdu, Chengdu, 610031, Sichuan, China, scu.edu.cn. Hauptthemen laut MEDLINE: Hydromorphone, Butorphanol, Acute Pain, Analgesics, Opioid. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute pain represents a distressing encounter for most patients in the emergency department (ED), profoundly impacting their quality of life. Nonsteroidal anti‐inflammatory drugs (NSAIDs) and morphine represent the most widely utilized analgesics; however, their clinical application in acute pain management is limited by their delayed onset of pharmacological action or significant risk of addiction. This study aimed to evaluate and compare the analgesic efficacy and safety of intramuscular hydromorphone and butorphanol in patients with acute pain in the ED.

Methods

This randomized controlled clinical trial randomly divided 199 patients with moderate to severe acute pain into two groups in a 1:1 ratio, receiving intramuscular injections of 1 mg of hydromorphone or butorphanol, respectively. Primary outcomes included pain intensity changes measured by the numerical rating scale (NRS), while secondary outcomes encompassed supplemental analgesic requirements, vital sign alterations, adverse event incidence, and patients’ destination.

Results

Comparative analysis revealed that hydromorphone administration resulted in significantly greater NRS score reductions compared to butorphanol, with superior pain relief rates observed at both 1 (56% vs. 44%, p = 0.013) and 2 h (69% vs. 60%, p = 0.002) intervals, and a greater proportion of apparent relief at 2 h (88% vs. 69%, p = 0.002), particularly in cases of severe pain (78% vs. 56%, p = 0.001). The hydromorphone group demonstrated significantly lower supplemental analgesic requirements at 2 h postadministration (0.0% vs. 6.1%, p = 0.031). There was no significant difference in the incidence of adverse reactions, the final destination, and the effects on heart rate, respiration, and oxygen saturation between the two groups. Common adverse reactions included dizziness or headache, nausea or vomiting, and injection pain.

Conclusion

Both hydromorphone and butorphanol were effective and safe in alleviating moderate to severe acute pain in the ED. However, hydromorphone exhibited superior analgesic effectiveness and a more rapid onset of action compared to butorphanol, particularly in cases of severe pain. Trial Registration: Chinese Registry of Clinical Trial: ChiCTR2400088376

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydromorphoneButorphanolAcute PainAnalgesics, OpioidHumansFemaleMaleMiddle AgedInjections, IntramuscularAdultEmergency Service, HospitalPain MeasurementTreatment OutcomeAged

Stichwörter der Autor:innen

acute painbutorphanolemergency departmenthydromorphone

Substanzen

HydromorphoneButorphanolAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Emergency, The Third People's Hospital of Chengdu, Chengdu, 610031, Sichuan, China, scu.edu.cn.
  • Department of Radiology, The Shenzhen Hospital of Southern Medical University, Shenzhen, 518101, Guangdong, China.
  • Department of Cardiology, The Third People's Hospital of Chengdu, Chengdu, 610031, Sichuan, China, scu.edu.cn.

ORCID-Profile: Yongping Huang, Xiaojing Peng, Bihua Zhang, Li Luo, Yufang Sun, Hang Dai, Jimei Zhang, Jia Yin, Shiqiang Xiong, Tao Xiang

Zitieren

APA

Huang, Y., Peng, X., Zhang, B., Luo, L., Sun, Y., Dai, H., Zhang, J., Yin, J., Xiong, S., & Xiang, T. (2026). The Analgesic Efficacy and Safety of Intramuscular Hydromorphone Versus Butorphanol for Acute Pain in the Emergency Department: A Randomized Trial. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/4981039

Vancouver

Huang Y, Peng X, Zhang B, Luo L, Sun Y, Dai H, et al. The Analgesic Efficacy and Safety of Intramuscular Hydromorphone Versus Butorphanol for Acute Pain in the Emergency Department: A Randomized Trial. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/4981039

BibTeX
@article{Huang2026,
  author = {Huang, Yongping and Peng, Xiaojing and Zhang, Bihua and Luo, Li and Sun, Yufang and Dai, Hang and Zhang, Jimei and Yin, Jia and Xiong, Shiqiang and Xiang, Tao},
  title = {The Analgesic Efficacy and Safety of Intramuscular Hydromorphone Versus Butorphanol for Acute Pain in the Emergency Department: A Randomized Trial},
  journal = {Pain Research and Management},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/prm/4981039}
}
Kostenlos starten →